Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Egalet (EGLT) Prices 16.7M Shares Offering at $1.80, Including Warrants
-
Egalet Announces Pricing of Public Offering of Common Stock and Warrants
-
Prometic announces closing of equity offerings for aggregate gross proceeds of $61.7 million
-
Cantor Fitzgerald Starts GenOn Energy (GEN) at Overweight
-
Egalet (EGLT) Announces Public Offering
-
Egalet Announces Proposed Public Offering of Common Stock and Warrants
-
Supernus Pharmaceuticals (SUPN) PT Raised to $49 at Cantor Fitzgerald
-
HealthEquity, Inc (HQY) PT Raised to $56 at Cantor Fitzgerald, "Management Meetings Confirm Positive Growth Outlook"
-
Easterly Acquisition Corp (EACQ) to Merge with JH Capital Group Holdings
-
JH Capital Group Holdings, LLC to Become Public Company Through a Combination with Easterly Acquisition Corp.
-
Cantor Fitzgerald Issues New Coverage On 9 Medical Equipment Names
-
Arena Pharma (ARNA): Ralinepag XR Shows Early Signs of Life - Cantor
-
Cantor Fitzgerald Starts Zimmer Biomet (ZBH) at Neutral
-
Cantor Fitzgerald Starts Wright Medical (WMGI) at Overweight
-
Cantor Fitzgerald Starts ViewRay Inc. (VRAY) at Overweight
-
Cantor Fitzgerald Starts Stryker (SYK) at Neutral
-
Cantor Fitzgerald Starts Intuitive Surgical (ISRG) at Neutral
-
Cantor Fitzgerald Starts Integra LifeSciences (IART) at Overweight
-
Cantor Fitzgerald Starts Hill-Rom Holdings (HRC) at Neutral
-
Cantor Fitzgerald Starts Baxter International (BAX) at Overweight
-
Cantor Fitzgerald Starts AxoGen, Inc. (AXGN) at Overweight
-
Pre-Open Movers 06/29: (STZ) (WATT) (WBA) Higher; (FRED) (RAD) (PIR) Lower (more...)
-
After-Hours Movers 06/28: (GEMP) (PRGS) (NXTD) Higher; (PIR) (BLCM) (DOC) Lower (more...)
-
Valeant Pharmaceuticals (VRX) PT Raised to $23 at Cantor Fitzgerald
-
Chembio Diagnostics (CEMI) Diagnostics Announces $21.2M At-The-Market Program
-
Chembio Diagnostics Announces At-The-Market Program
-
Justin Short Joins Hunt Mortgage Group as Managing Director
-
Pre-Open Movers 06/27: (CGIX) (ARNA) (DRI) Higher; (ALDR) (FNJN) (NEOS) Lower (more...)
-
Neos Therapeutics (NEOS) Prices $32.4M Common Stock Offering
-
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $32.4 Million of Common Stock
-
Rambler Metals & Mining PLC: Exploration Update
-
After-Hours Stock Movers 06/26: (AMRN) (ESPR) (RAD) Higher; (FNJN) (NEOS) (BLUE) Lower (more...)
-
UPDATE: Cantor Fitzgerald Assumes Amarin Corporation (AMRN) at Overweight
-
Neos Therapeutics (NEOS) Plans $30M Common Stock Offering
-
Neos Therapeutics Announces Proposed Offering of Common Stock
-
Cantor Fitzgerald Assumes Cidara Therapeutics (CDTX) at Overweight, Sees Underappreciated Sales Potential
-
bluebird bio (BLUE) PT Raised to $39 at Cantor Fitzgerald, Keeps 'Underweight' Rating
-
The Trade Desk (TTD) PT Raised to $60 at Cantor Fitzgerald; 'Extending DCF-Based Model to Seven Years'
-
Cantor Fitzgerald Assumes Nabriva Therapeutics AG (NBRV) at Overweight
-
Teva (TEVA) Remanezumab Can Lead in Potential $8-$10B CGRP Market
-
Pre-Open Movers 06/22: (ORCL) (HAIN) (SPLS) (AA) Higher; (ENSC) (KMDA) (SCS) Lower (more...)
-
Spring Bank Pharmaceuticals (SBPH) Prices 2.88M Common Stock Offering at $13/Share
-
Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock
-
UPDATE: Cantor Fitzgerald Starts Dermira (DERM) at Overweight
-
After-Hours Stock Movers 06/21: (ORCL) (PRTK) (NRZ) Higher; (SCS) (JCAP) (THMC) Lower (more...)
-
Cantor Fitzgerald Assumes Paratek Pharmaceuticals (PRTK) at Overweight
-
Spring Bank Pharmaceuticals (SBPH) Announces Proposed Common Share Offering
-
Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
MCAP LLC Expands ADR & Foreign Ordinary Market Making Operation
-
Reminder: Capital Link's 4th Annual Dissect ETFs Forum


